Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TOLTERODINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Tannenbaum, C; Bachand, G; Dubeau, CE; Kuchel, GA
      Experience of an incontinence clinic for older women: No apparent age limit for potential physical and psychological benefits

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    2. Enskat, R; Deaney, CN; Glickman, S
      Systemic effects of intravesical atropine sulphate

      BJU INTERNATIONAL
    3. Hjalmas, K; Hellstrom, AL; Mogren, K; Lackgren, G; Stenberg, A
      The overactive bladder in children: a potential future indication for tolterodine

      BJU INTERNATIONAL
    4. Wein, AJ
      Pharmacological agents for the treatment of urinary incontinence due to overactive bladder

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    5. Lemack, GE
      Overactive bladder: Optimizing quality of care

      AMERICAN JOURNAL OF MANAGED CARE
    6. McGhan, WF
      Cost effectiveness and quality of life considerations in the treatment of patients with overactive bladder

      AMERICAN JOURNAL OF MANAGED CARE
    7. English, BA; Still, DJ; Harper, J; Saklad, SR
      Failure of tolterodine to treat clozapine-induced nocturnal enuresis

      ANNALS OF PHARMACOTHERAPY
    8. Oki, T; Yamada, S; Tohma, A; Kimura, R
      Muscarinic receptor binding characteristics in rat tissues after oral administration of oxybutynin and propiverine

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    9. Wefer, J; Truss, MC; Jonas, U
      Tolterodine: an overview

      WORLD JOURNAL OF UROLOGY
    10. Jacquetin, B; Wyndaele, JJ
      Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    11. Jones, JB; Giles, BK; Brizendine, EJ; Cordell, WH
      Sublingual hyoscyamine sulfate in combination with ketorolac tromethamine for ureteral colic: A randomized, double-blind, controlled trial

      ANNALS OF EMERGENCY MEDICINE
    12. Olsson, B; Landgren, BM
      The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel

      CLINICAL THERAPEUTICS
    13. Alvan, G; Bertilsson, L; Dahl, ML; Ingelman-Sundberg, M; Sjoqvist, F
      Moving toward genetic profiling in patient care: The scope and rationale of pharmacogenetic/ecogenetic investigation

      DRUG METABOLISM AND DISPOSITION
    14. Pahlman, I; d'Argy, R; Nilvebrant, L
      Tissue distribution of tolterodine, a muscarinic receptor antagonist, and transfer into fetus and milk in mice

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    15. Pahlman, I; Kankaanranta, S; Palmer, L
      Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog - Interspecies relationship comparing with human pharmacokinetics

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    16. Harvey, MA; Baker, K; Wells, GA
      Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: A meta-analysis

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    17. Malone-Lee, JG; Walsh, JB; Maugourd, MF
      Tolterodine: A safe and effective treatment for older patients with overactive bladder

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    18. Yono, M; Yoshida, M; Takahashi, W; Inadome, A; Ueda, S
      Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle

      BJU INTERNATIONAL
    19. Abrams, P; Kelleher, CJ; Kerr, LA; Rogers, RG
      Overactive bladder significantly affects quality of life

      AMERICAN JOURNAL OF MANAGED CARE
    20. Ouslander, JG; Shih, YCT; Malone-Lee, J; Luber, K
      Overactive bladder: Special considerations in the geriatric population

      AMERICAN JOURNAL OF MANAGED CARE
    21. Movig, KLL; Egberts, ACG; Lenderink, AW; Leufkens, HGM
      Selective prescribing of spasmolytics

      ANNALS OF PHARMACOTHERAPY
    22. Durand, A; Serment, G; Bladou, F
      Drug therapy for urinary incontinence

      PRESSE MEDICALE
    23. Homma, Y; Kondo, Y; Takahashi, S; Kitamura, T; Kawabe, K
      Reproducibility of cystometry in overactive detrusor

      EUROPEAN UROLOGY
    24. Uckert, S; Stief, CG; Odenthal, KP; Truss, MC; Lietz, B; Jonas, U
      Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    25. Jonas, U; Hofner, K; Madersbacher, H; Holmdahl, TH; Freeman, R; Anderstrom, C; Mattiasson, A; Abrams, P
      Tolterodine - A new drug for the treatment of urge incontinence. Clinical and urodynamic efficacy and comparison with oxybutynin

      AKTUELLE UROLOGIE
    26. Davies, HML; Stafford, DG; Hansen, T
      Catalytic asymmetric synthesis of diarylacetates and 4,4-diarylbutanoates.A formal asymmetric synthesis of (+)-sertraline

      ORGANIC LETTERS
    27. Kobelt, G; Kirchberger, I; Malone-Lee, J
      Quality-of-life aspects of the overactive bladder and the effect of treatment with tolterodine

      BJU INTERNATIONAL
    28. Abrams, P; Larsson, G; Chapple, C; Wein, AJ
      Factors involved in the success of antimuscarinic treatment

      BJU INTERNATIONAL
    29. Messelink, EJ
      Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist

      BJU INTERNATIONAL
    30. Swart, R; Koivisto, P; Markides, KE
      Capillary solid-phase extraction-tandem mass spectrometry for fast quantification of free concentrations of tolterodine and two metabolites in ultrafiltered plasma samples

      JOURNAL OF CHROMATOGRAPHY B
    31. Eglen, RM; Choppin, A; Dillon, MP; Hegde, S
      Muscarinic receptor ligands and their therapeutic potential

      CURRENT OPINION IN CHEMICAL BIOLOGY
    32. Colucci, VJ; Rivey, MP
      Tolterodine-warfarin drug interaction

      ANNALS OF PHARMACOTHERAPY
    33. Ruscin, JM; Morgenstern, NE
      Tolterodine use for symptoms of overactive bladder

      ANNALS OF PHARMACOTHERAPY
    34. Schwantes, U; Topfmeier, P
      Importance of pharmacological and physicochemical properties for toleranceof antimuscarinic drugs in the treatment of detrusor instability and detrusor hyperreflexia - Chances for improvement of therapy

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    35. Barras, M; Coste, A; Eon, MT; Guillot, E
      Pharmacological characterization of muscarinic receptors implicated in rabbit detrusor muscle contraction and activation of inositol phospholipid hydrolysis in rabbit detrusor and parotid gland

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    36. Brynne, N; Svanstrom, C; Aberg-Wistedt, A; Hallen, B; Bertilsson, L
      Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    37. Brynne, N; Forslund, C; Hallen, B; Gustafsson, LL; Bertilsson, L
      Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    38. Brynne, N; Bottiger, Y; Hallen, B; Bertilsson, L
      Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    39. Pahlman, Z; Gozzi, P
      Serum protein binding of tolterodine and its major metabolites in humans and several animal species

      BIOPHARMACEUTICS & DRUG DISPOSITION
    40. Wallis, RM; Napier, CM
      Muscarinic antagonists in development for disorders of smooth muscle function

      LIFE SCIENCES
    41. Yono, M; Yoshida, M; Wada, Y; Kikukawa, H; Takahashi, W; Inadome, A; Seshita, H; Ueda, S
      Pharmacological effects of tolterodine on human isolated urinary bladder

      EUROPEAN JOURNAL OF PHARMACOLOGY
    42. Goessl, C; Sauter, T; Michael, T; Wettig, I; Weikert, S; Miller, K
      Tolterodine for children with myelomeningocele and detrusor hyperreflexia:First results

      AKTUELLE UROLOGIE
    43. KHULLAR V; CARDOZO L
      INCONTINENCE IN THE ELDERLY

      Current opinion in obstetrics & gynecology
    44. KOBELT G; JONSSON L; MATTIASSON A
      COST-EFFECTIVENESS OF NEW TREATMENTS FOR OVERACTIVE BLADDER - THE EXAMPLE OF TOLTERODINE, A NEW MUSCARINIC AGENT - A MARKOV MODEL

      Neurourol. urodyn.
    45. VANKERREBROECK PEVA; AMARENCO G; THUROFF JW; MADERSBACHER HG; LOCK MTWT; MESSELINK EJ; SOLER JM
      DOSE-RANGING STUDY OF TOLTERODINE IN PATIENTS WITH DETRUSOR HYPERREFLEXIA

      Neurourol. urodyn.
    46. ANDERSSON PG; SCHINK HE; OSTERLUND K
      ASYMMETRIC TOTAL SYNTHESIS OF (-TOLTERODINE, A NEW MUSCARINIC RECEPTOR ANTAGONIST, VIA COPPER-ASSISTED ASYMMETRIC CONJUGATE ADDITION OF ARYL GRIGNARD-REAGENTS TO 3-PHENYL-PROP-2-ENOYL-OXAZOLIDINONES())

      Journal of organic chemistry
    47. GILLBERG PG; SUNDQUIST S; NILVEBRANT L
      COMPARISON OF THE IN-VITRO AND IN-VIVO PROFILES OF TOLTERODINE WITH THOSE OF SUBTYPE-SELECTIVE MUSCARINIC RECEPTOR ANTAGONISTS

      European journal of pharmacology
    48. ABRAMS P; FREEMAN R; ANDERSTROM C; MATTIASSON A
      TOLTERODINE, A NEW ANTIMUSCARINIC AGENT - AS EFFECTIVE BUT BETTER TOLERATED THAN OXYBUTYNIN IN PATIENTS WITH AN OVERACTIVE BLADDER

      British Journal of Urology
    49. RENTZHOG L; STANTON SL; CARDOZO L; NELSON E; FALL M; ABRAMS P
      EFFICACY AND SAFETY OF TOLTERODINE IN PATIENTS WITH DETRUSOR INSTABILITY - A DOSE-RANGING STUDY

      British Journal of Urology
    50. Wagg, A; Malone-Lee, J
      The management of urinary incontinence in the elderly

      BRITISH JOURNAL OF UROLOGY
    51. Swart, R; Koivisto, P; Markides, KE
      Column switching in capillary liquid chromatography tandem mass spectrometry for the quantitation of pg/ml concentrations of the free basic drug tolterodine and its active 5-hydroxymethyl metabolite in microliter volumes of plasma

      JOURNAL OF CHROMATOGRAPHY A
    52. BRYNNE N; STAHL MMS; HALLEN B; EDLUND PO; PALMER L; HOGLUND P; GABRIELSSON J
      PHARMACOKINETICS AND PHARMACODYNAMICS OF TOLTERODINE IN MAN - A NEW DRUG FOR THE TREATMENT OF URINARY-BLADDER OVERACTIVITY

      International journal of clinical pharmacology and therapeutics
    53. PALMER L; ANDERSSON L; ANDERSSON T; STENBERG U
      DETERMINATION OF TOLTERODINE AND THE 5-HYDROXYMETHYL METABOLITE IN PLASMA, SERUM AND URINE USING GAS-CHROMATOGRAPHY MASS-SPECTROMETRY

      Journal of pharmaceutical and biomedical analysis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 07:38:01